€196.50
0.00% day before yesterday
Frankfurt, Sep 06, 08:02 am CET
ISIN
DE0007474041
Symbol
PHH2
Sector

Paul Hartmann Stock price

€196.50
+11.50 6.22% 1M
-19.50 9.03% 6M
-9.50 4.61% YTD
-9.50 4.61% 1Y
-175.50 47.18% 3Y
-99.50 33.61% 5Y
-133.50 40.45% 10Y
Frankfurt, Closing price Fri, Sep 06 2024
+0.00 0.00%
ISIN
DE0007474041
Symbol
PHH2
Sector

Key metrics

Market capitalization €697.92m
Enterprise Value €1.04b
P/E (TTM) P/E ratio 11.72
EV/Sales (TTM) EV/Sales 0.44
P/S ratio (TTM) P/S ratio 0.29
P/B ratio (TTM) P/B ratio 0.64
Dividend yield 4.07%
Last dividend (FY23) €8.00
Revenue growth (TTM) Revenue growth 1.25%
Revenue (TTM) Revenue €2.38b
EBIT (operating result TTM) EBIT €110.11m
EPS (TTM) EPS €16.76
Show more

Is Paul Hartmann a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Financial data from Paul Hartmann

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
2,383 2,383
1% 1%
100%
- Direct Costs 1,759 1,759
0% 0%
74%
625 625
5% 5%
26%
- Selling and Administrative Expenses 411 411
5% 5%
17%
- Research and Development Expense - -
-
-
214 214
34% 34%
9%
- Depreciation and Amortization 104 104
0% 0%
4%
EBIT (Operating Income) EBIT 110 110
95% 95%
5%
Net Profit 60 60
156% 156%
2%

In millions EUR.

Don't miss a Thing! We will send you all news about Paul Hartmann directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Paul Hartmann Stock News

EQS
9 months ago
Gemäß der aktuellen Mehrjahresplanung des Vorstands der PAUL HARTMANN AG, der der Aufsichtsrat heute zugestimmt hat, erwartet die HARTMANN GRUPPE für das Geschäftsjahr 2024 ein moderates organisches Umsatzwachstum und ein bereinigtes EBITDA in einer Bandbreite von 200 bis 240 Mio. EUR. Dies stell...
EQS
10 months ago
HARTMANN hat 2023 innovative Produkte auf den Markt gebracht sowie Projekte mit substanziellen Kostenverbesserungen umgesetzt. Das Transformationsprogramm wird im laufenden Geschäftsjahr mit knapp 50 Mio. EUR zum bereinigten EBITDA beitragen, das ist deutlich mehr als geplant. Trotz leichter Erho...
EQS
more than one year ago
Aufgrund der wirtschaftlichen und geopolitischen Herausforderungen verschlechtern sich die Marktbedingungen, insbesondere steigen die Material-, Transport-, Lohn- und Energiekosten, u.a. aufgrund von zeitlich auslaufenden Absicherungen, deutlich. Das Unternehmen trägt auch Mehrkosten durch höhere...

Company Profile

Paul Hartmann AG engages in the production of medical and hygiene products. It operates through the following business segments: Wound Management, Incontinence Management, Infection Management, and Other Group Activities. The Wound Management segment includes wound dressing and products for compression therapy and immobilization. The Incontinence Management segment provides incontinence hygiene, medical records, and products for patient and medical skin care. The Infection Management segment consists of surgery sets, surgical clothing, and surgical examination gloves. The Other Group Activities segment focuses on the areas of cotton wool products, feminine hygiene, baby hygiene, medical consumer goods, medicated and dietary supplements, body care and bath products, and commercial business. The company was founded in 1818 and is headquartered in Heidenheim, Germany.

Head office Germany
CEO Britta Fuenfstueck
Employees 10,168
Founded 1818
Website www.hartmann.info

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today